HCV is treatable and often curable with direct-acting antiviral (DAA) medications. These medications target specific steps in the HCV life cycle to prevent the virus from replicating. The treatment regimen typically lasts 8-12 weeks and has a high success rate. Early diagnosis and treatment are crucial to prevent complications such as liver cirrhosis and liver cancer.
